Search results for: Health Data and Statistics
Filter search results
Making the Most of Health Data to Deliver Pharmaceutical Innovation: What Are the Legal Barriers?
20 December 2018
…our health data are collected and used to drive innovation and improvements in health care delivery. A shared understanding of the value to society of pharmaceutical research is therefore necessary…
Seven reflections on the UK EQ-5D-5L value set – and what comes next
30 March 2026
…working on the methodological foundations that underpin how child health states should be valued – including whether adult and adolescent preferences differ, how different valuation methods and perspectives affect results, and how to anchor…
OHE is Recruiting a Head of Health Statistics
15 April 2013
…OHE is recruiting a highly motivated, experienced and energetic statistician to head its statistics function and contribute to its core activities. The Head of Statistics is expected to provide leadership…
Recent Statistics on Orphan Approvals in Scotland and England
23 August 2011
…same methodology, this new analysis focuses on decisions taken on orphan drugs by the Scottish Medicines Consortium (SMC) and the National Institute for Health and Clinical Excellence (NICE). Included are…
OHE’s submission for the DHSC’s next 10 years of planning
9 December 2024
…consider how scarce resources are allocated in already over-stretched and under-funded health care systems. Choices and trade-offs in healthcare are literally a matter of health and death. Within this paradigm,…
Caring about Carers: Improving Consideration of the Burden of Informal Caring in HTA
11 April 2023
…of Health and Care Excellence (NICE), and when it is considered, the data are often much poorer than equivalent outcomes data for patients ( Pennington, 2020). There are also important…
Around the world in HTAs: China – From fragmentation to function
2 September 2025
…remained informal and fragmented. In 2016 and 2017, the Ministry of Human Resources and Social Security and the National Health and Family Planning Commission (which is now the National Health…
The Dynamics of Drug Shortages
9 January 2024
…price change of other products with the same molecule, iii) market concentration, iv) demand and competition, and v) patent expiration), which can be used to determine shortages’ factors and value…
Achieving Accelerated Patient Access to Cancer Care in Europe
3 November 2025
…regulatory pathways to support timely access to promising therapies in areas of high unmet medical need. On the other hand, Health Technology Assessment (HTA) and pricing and reimbursement (P&R) processes…